GlassScriptPhysician profile
Ashley N Pair
NPI 1437700051
$853.26
in general payments reported to CMS, 2019-2025
17 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $82.97 · 2023: $390 · 2024: $176 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $161.82 | 2022-2024 | Caldolor |
| Ferring Pharmaceuticals INC. | $117.25 | 2025 | Euflexxa |
| Abbvie INC. | $72.51 | 2023-2024 | |
| Kci USA, INC. | $63.62 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice, 3m Tegaderm |
| Ethicon US, LLC | $60.66 | 2023-2024 | Echelon Flex, Enseal, Echelon; Endopath |
| Integra Lifesciences Corporation | $58.64 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $52.96 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Vertex Pharmaceuticals Incorporated | $50.34 | 2025 | |
| La Jolla Pharmaceutical Company | $43.42 | 2023-2024 | Giapreza |
| Davol INC. | $39.87 | 2022-2023 | Phasix Mesh |
| Hydrofera LLC | $23.04 | 2022 | |
| Smith+Nephew, INC. | $20.86 | 2023 | Pico 7 |
| Medtronic, INC. | $19.24 | 2024 | Progrip |
| Bioventus LLC | $18.82 | 2025 | Durolane |
| Zimmer Biomet Holdings, INC. | $17.74 | 2025 | Gps III Platelet Concentration System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $16.32 | 2022 | |
| Solventum Corporation | $16.15 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Pair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.